ARTICLE | Clinical News
Sebclair regulatory update
November 6, 2006 8:00 AM UTC
FDA granted 510(k) clearance to Sebclair to treat seborrheic dermatitis. Chester Valley (Malvern, Penn.) has U.S. marketing rights to the non-steroidal cream, which FDA classified as a device, and exp...